(Q44874904)

7 December 2017

Variability in activity of hepatic CYP3A4 in patients infected with HIV. (English)

1 reference

7 December 2017

Slain D

1

1 reference

7 December 2017

Pakyz A

2

1 reference

7 December 2017

Israel DS

3

1 reference

7 December 2017

Monroe S

4

1 reference

7 December 2017

Polk RE

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

7 December 2017

1 reference

7 December 2017

20

1 reference

7 December 2017

8

1 reference

7 December 2017

898-907

1 reference

7 December 2017

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Indinavir concentrations and antiviral effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Effect of age and gender on the activity of human hepatic CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Effect of disease states on theophylline elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

The effect of chronic retrovirus infection and immune dysfunction on the P-450-mediated activation of acetaminophen in mouse liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

The erythromycin breath test as a predictor of cyclosporine blood levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

The erythromycin breath test predicts the clearance of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

CYP3A4 and the erythromycin breath test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Drug metabolism in extrahepatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Cytokines in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Cytochrome P450 3A: ontogeny and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Metabolism-based drug interactions involving oral azole antifungals in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.898.35262

10.1592/PHCO.20.11.898.35262

21 January 2018

Identifiers

DOI

1 reference

release_xi7mndw5fjhgziuh5nufyd6uqm

7 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xi7mndw5fjhgziuh5nufyd6uqm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference